VEGF Receptor Signal Transduction

Sci. STKE, 11 December 2001
Vol. 2001, Issue 112, p. re21
DOI: 10.1126/stke.2001.112.re21

VEGF Receptor Signal Transduction

  1. Taro Matsumoto and
  2. Lena Claesson-Welsh*
  1. Department of Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Dag Hammarskjöldsv. 20, 751 85 Uppsala, Sweden.
  1. Corresponding author. E-mail: Lena.Welsh{at}genpat.uu.se

Abstract

The family of vascular endothelial growth factors (VEGFs) currently includes VEGF-A, -B, -C, -D, -E, and placenta growth factor (PlGF). Several of these factors, notably VEGF-A, exist as different isoforms, which appear to have unique biological functions. The VEGF family proteins bind in a distinct pattern to three structurally related receptor tyrosine kinases, denoted VEGF receptor-1, -2, and -3. Neuropilins, heparan-sulfated proteoglycans, cadherins, and integrin αvβ3 serve as coreceptors for certain but not all VEGF proteins. Moreover, the angiogenic response to VEGF varies between different organs and is dependent on the genetic background of the animal. Inactivation of the genes for VEGF-A and VEGF receptor-2 leads to embryonal death due to the lack of endothelial cells. Inactivation of the gene encoding VEGF receptor-1 leads to an increased number of endothelial cells, which obstruct the vessel lumen. Inactivation of VEGF receptor-3 leads to abnormally organized vessels and cardiac failure. Although VEGF receptor-3 normally is expressed only on lymphatic endothelial cells, it is up-regulated on vascular as well as nonvascular tumors and appears to be involved in the regulation of angiogenesis. A large body of data, such as those on gene inactivation, indicate that VEGF receptor-1 exerts a negative regulatory effect on VEGF receptor-2, at least during embryogenesis. Recent data imply a positive regulatory role for VEGF receptor-1 in pathological angiogenesis. The VEGF proteins are in general poor mitogens, but binding of VEGF-A to VEGF receptor-2 leads to survival, migration, and differentiation of endothelial cells and mediation of vascular permeability. This review outlines the current knowledge about the signal transduction properties of VEGF receptors, with focus on VEGF receptor-2.

Citation:

T. Matsumoto and L. Claesson-Welsh, VEGF Receptor Signal Transduction. Sci. STKE 2001, re21 (2001).

Alterations in expression of elastogenic and angiogenic genes by different conditions of mechanical ventilation in newborn rat lung
A. A. Kroon, J. Wang, and M. Post
Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L639-L649 (1 April 2015)

KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2
K. H. Yamada, Y. Nakajima, M. Geyer, K. K. Wary, M. Ushio-Fukai, Y. Komarova, and A. B. Malik
J. Cell Sci. 127, 4518-4530 (15 October 2014)

Less stress, more success? Oncological implications of surgery-induced oxidative stress
D. P. O'Leary, J. H. Wang, T. G. Cotter, and H. P. Redmond
Gut 62, 461-470 (1 March 2013)

The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
M. W. Kieran, R. Kalluri, and Y.-J. Cho
Cold Spring Harb Perspect Med 2, a006593-a006593 (1 December 2012)

Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization in a Murine Model of Hindlimb Ischemia
R. Nagahama, T. Matoba, K. Nakano, S. Kim-Mitsuyama, K. Sunagawa, and K. Egashira
Arterioscler. Thromb. Vasc. Bio. 32, 2427-2434 (1 October 2012)

NHERF-2 maintains endothelial homeostasis
R. Bhattacharya, E. Wang, S. K. Dutta, P. K. Vohra, G. E, Y. S. Prakash, and D. Mukhopadhyay
Blood 119, 4798-4806 (17 May 2012)

Axl is essential for VEGF-A-dependent activation of PI3K/Akt
G.-X. Ruan, and A. Kazlauskas
EMBO J. 31, 1692-1703 (4 April 2012)

Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair
M. J. Webber, J. Tongers, C. J. Newcomb, K.-T. Marquardt, J. Bauersachs, D. W. Losordo, and S. I. Stupp
Proc. Natl. Acad. Sci. USA 108, 13438-13443 (16 August 2011)

Signal transduction by vascular endothelial growth factor receptors
S. Koch, S. Tugues, X. Li, L. Gualandi, and L. Claesson-Welsh
Biochem. J. 437, 169-183 (15 July 2011)

Angiogenic Growth Factors Are New and Essential Players in the Sustained Relaxin Vasodilatory Pathway in Rodents and Humans
J. T. McGuane, L. A. Danielson, J. E. Debrah, J. P. Rubin, J. Novak, and K. P. Conrad
Hypertension 57, 1151-1160 (1 June 2011)

Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6
V. Manickam, A. Tiwari, J.-J. Jung, R. Bhattacharya, A. Goel, D. Mukhopadhyay, and A. Choudhury
Blood 117, 1425-1435 (27 January 2011)

Inhibition of Angiogenesis by Recombinant VEGF Receptor Fragments
D. Ahmadvand, F. Rahbarizadeh, F. Jafari Iri-Sofla, G. Namazi, S. Khaleghi, B. Geramizadeh, P. Pasalar, H. Karimi, and S. H. Aghaee Bakhtiari
Lab Med 41, 417-422 (1 July 2010)

Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation
Y. Shi, M. Song, R. Guo, H. Wang, P. Gao, W. Shi, and L. Huang
Exp Biol Med (Maywood) 235, 317-325 (1 March 2010)

Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells
T. T. Chen, A. Luque, S. Lee, S. M. Anderson, T. Segura, and M. L. Iruela-Arispe
JCB 188, 595-609 (22 February 2010)

Membrane Ganglioside Enrichment Lowers the Threshold for Vascular Endothelial Cell Angiogenic Signaling
Y. Liu, J. McCarthy, and S. Ladisch
Cancer Res. 66, 10408-10414 (1 November 2006)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882